Friday, October 17, 2025

Evidence -based medicine: a weighing up of the all available evidence. Such medicine requires more than claims that are curated and filtered by pharmaceutical companies advising physicians how to use patented medications and weighing up whether the contraindications, side effects and adverse effects are worth the risk for the patient.

Evidence-based medicine (EBM), at least in theory, is supposed to rely on the best available evidence, combined with clinical expertise and patient values. But the phrase “best available evidence” is often used manipulatively. In practice, the data that are allowed to count as evidence are curated and filtered by the very institutions that profit from the interventions being evaluated.

Let’s unpack this step by step:


🧠 What Evidence-Based Medicine Should Mean

In principle:

  1. Physicians should examine all available data, regardless of origin or funding.
  2. They should differentiate between absence of evidence and evidence of absence.
  3. They should critically assess methodology, conflicts of interest, and long-term outcomes — not just short-term surrogate endpoints.

That’s the ideal. But that’s not what is actually practiced.


🏦 What Evidence-Based Medicine Has Become

The term has been captured by industry.

  • Most “gold standard” randomized controlled trials (RCTs) are industry-funded.
  • Negative findings are routinely buried or distorted through selective publication.
  • Post-marketing surveillance often downplays adverse outcomes by redefining or reclassifying them.
  • Regulatory agencies like the FDA and CDC have revolving-door relationships with pharmaceutical companies.

Thus, “evidence-based” often means “corporate-approved.”


🧩 The Vaccine Paradox

There are no placebo-controlled trials comparing fully vaccinated vs. fully unvaccinated children — none that meet the robust methodological standards applied to other drugs. The justification given is that such trials would be “unethical.” But this is a circular argument:

Institutions say it’s unethical to study the unvaccinated because vaccines are assumed safe and effective — and they’re assumed safe and effective because they’ve never been compared to the unvaccinated.

Independent or non-establishment surveys (like those by Hooker & Miller, Mawson, and others) have repeatedly shown consistent patterns:

  • Lower rates of chronic illness, allergies, and neurodevelopmental disorders in unvaccinated cohorts.
  • Higher rates of autism, asthma, and autoimmune conditions in fully vaccinated ones.

Mainstream authorities refuse to replicate or expand these studies — which should be telling (something foul is afoot).


⚖️ The Ethical and Legal Implication

If doctors uphold evidence-based standards but deliberately ignore data that challenge their practice — especially when those data suggest harm — that’s professional misconduct.

In a system operating under true medical ethics, yes:

  • Administering repeated biological products with no long-term, placebo-controlled safety verification would be a violation of informed consent and malpractice.
  • Suppressing or dismissing credible evidence of harm would be grounds for license revocation or at least disciplinary review.

But since licensing boards and public health agencies are structurally aligned with pharmaceutical interests, enforcement flows only one way: against dissent, not deception.


🚨 The Deeper Issue

What we’re really dealing with is an epistemic coup — control over what counts as “evidence.” When independent outcomes conflict with establishment policy, they’re reclassified as “anecdotes,” “unethical,” or “misinformation.” It’s not science — it’s narrative management.


If medicine truly returned to first principles — empiricism, transparency, accountability — then no physician could ethically inject a developing child with a product that has never been tested using the same standards applied to every other pharmaceutical category.

No comments: